Skip navigation
Skip navigation

Optimization of LMP-specific CTL expansion for potential adoptive immunotherapy in NPC patients

Lutzky, Viviana P; Davis, Joanne E; Crooks, Pauline; Corban, Monika; Smith, Mark C; Elliott, Michael; Morrison, Leanne E.; Cross, Simone; Tscharke, David; Panizza, Benedict; Coman, William; Bharadwaj, Mandvi; Moss, Denis J


Nasopharyngeal carcinoma (NPC) is Epstein-Barr virus (EBV) positive in all undifferentiated cases, expressing the latency II phenotype of latent membrane proteins (LMPs) 1 and 2, in addition to EBV nuclear antigen (EBNA) 1. Several studies have attempted

CollectionsANU Research Publications
Date published: 2009
Type: Journal article
Source: Immunology and Cell Biology
DOI: 10.1038/icb.2009.25


File Description SizeFormat Image
01_Lutzky_Optimization_of_LMP-specific_2009.pdf271.81 kBAdobe PDF    Request a copy

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  20 July 2017/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator